The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN).
The investment seeks long-term growth of capital.
The fund invests primarily in foreign equity securities. It has no limitation on the percentage of assets that are invested in any one country or denominated in any one currency, but the fund typically invests in foreign securities of at least 20 countries. The fund invests in equity securities regardless of market capitalization size (small, medium or large) and style (growth or value).
The average market capitalization across the Principal Diversified Intl R3 MF is 139.36B. The market cap for tickers in the group ranges from 214.07M to 273.98B. ASML holds the highest valuation in this group at 273.98B. The lowest valued company is III at 214.07M.
The average weekly volume growth across all stocks in the Principal Diversified Intl R3 MF was -68%. For the same stocks of the MF, the average monthly volume growth was -52% and the average quarterly volume growth was -34%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 45
P/E Growth Rating: 41
Price Growth Rating: 50
SMR Rating: 62
Profit Risk Rating: 42
Seasonality Score: 4 (-100 ... +100)